Jiefu Peng
Overview
Explore the profile of Jiefu Peng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
69
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhang S, Wang Y, Xu G, Dong C, Tian H, Li C, et al.
Vaccines (Basel)
. 2024 Nov;
12(11).
PMID: 39591114
Background: Previous SARS-CoV-2 infection provides some level of protection against reinfection. However, few studies have evaluated the neutralizing antibody (NAb) response after Delta variant infection and its ability to prevent...
2.
Peng J, Feng J, Ji H, Kong X, Hong J, Zhu L, et al.
Antibiotics (Basel)
. 2024 Jun;
13(6).
PMID: 38927185
Background: In recent years, global concern over increasing multidrug resistance (MDR) among various serotypes has grown significantly. However, reports on MDR Paratyphi B remain scarce, let alone the extensively drug-resistant...
3.
Chu J, Dai Q, Dong C, Kong X, Tian H, Li C, et al.
Front Public Health
. 2024 Jun;
12:1364048.
PMID: 38873290
Background: It is important to figure out the immunity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) reinfection to understand the response of humans to viruses. A serological survey for...
4.
Simayi A, Li C, Chen C, Wang Y, Dong C, Tian H, et al.
Front Immunol
. 2023 Feb;
14:1083523.
PMID: 36761738
Background: The quantitative level and kinetics of neutralizing antibodies (NAbs) in individuals with Omicron breakthrough infections may differ from those of vaccinated individuals without infection. Therefore, we aimed to evaluate...
5.
Zhu L, Mao N, Yi C, Simayi A, Feng J, Feng Y, et al.
Emerg Microbes Infect
. 2022 Nov;
12(1):2146535.
PMID: 36373485
How much the vaccine contributes to the induction and development of neutralizing antibodies (NAbs) of breakthrough cases relative to those unvaccinated-infected cases is not fully understood. We conducted a prospective...
6.
Peng J
J Healthc Eng
. 2022 Feb;
2022:2092034.
PMID: 35186221
In recent years, spinal disorders, spinal deformities, and scoliosis have become more frequent, especially chronic systemic inflammatory diseases, such as early-onset scoliosis, idiopathic scoliosis, and ankylosis spondylitis, which have unknown...
7.
Zhang S, Xu K, Li C, Zhou L, Kong X, Peng J, et al.
Front Immunol
. 2022 Feb;
13:829665.
PMID: 35154152
Background: Understanding the long-term kinetic characteristics of SARS-CoV-2 antibodies and the impact of inactivated vaccines on SARS-CoV-2 antibodies in convalescent patients can provide information for developing and improving vaccination strategies...
8.
Wang S, Zou X, Li Z, Fu J, Fan H, Yu H, et al.
Front Public Health
. 2022 Jan;
9:791600.
PMID: 35004593
At present, the global sever acute respiratory syndrome coronavirus 2 (SARS-CoV-2) situation is still grim, and the risk of local outbreaks caused by imported viruses is high. Therefore, it is...
9.
Zhu L, Xu X, Zhu B, Guo X, Xu K, Song C, et al.
Microbiol Spectr
. 2021 Sep;
9(2):e0059021.
PMID: 34550000
To assess the persistence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies produced by natural infection and describe the serological characteristics over 7 months after symptom onset among coronavirus...
10.
Chen L, Huo X, Qi X, Liu C, Huang H, Yu H, et al.
Transbound Emerg Dis
. 2020 Apr;
67(5):2118-2125.
PMID: 32248624
Avian influenza A(H5N6) keeps evolving, causing outbreaks in birds and sporadic infections in human. Here, we report a fatal paediatric infection caused by a novel reassortant H5N6 virus. The patient...